Navigation Links
New Treatment for Rosacea

A new, safe, and promising therapy option may be more effective in treating the 14 million Americans who suffer from rosacea, a chronic skin disease that causes persistent redness on the nose and cheeks.

Researchers applied a new formulation of azelaic acid gel to the faces of rosacea sufferers. //The new product contains 15 percent azelaic acid and is specifically made for rosacea. Typically it has a different formula and is used to treat acne. Many rosacea patients are generally treated with metronidazole gel, an antibiotic commonly used to treat infections of the small intestines and colon.

In a study, researchers compared the safety and efficacy of azelaic gel versus metronidazole gel in rosacea patients. They found the azelaic gel was better at reducing the number of lesions associated with rosacea and better at reducing the redness in patient’s faces than the metronidazole gel. Also, the metronidazole gel’s effectiveness plateaued after eight weeks, but the azelaic gel showed progressive effectiveness through the 15-week study.

Rosacea causes tiny blood vessels in the face to enlarge and become more visible through the skin. The vessels appear as tiny red lines, called telangiectasias. Rosacea can also cause pimples to occur, even though rosacea usually affects adults between ages 30 and 60. Study authors say the disease usually responds well to topical antimicrobials -- creams or gels that kill microorganisms like bacteria even though doctors have not been able to identify a microbiologic cause of rosacea. There is no cure for rosacea and if left untreated, it worsens.

Researchers say their study shows azelaic acid gel is consistently superior to metronidazole gel in improving the principal signs of rosacea, such as redness and inflammation. In the azelaic acid gel group, 78 percent of the patients rated their improvement as excellent or good, compared to 64 percent in the metronidazole gel grou.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
(Date:4/28/2017)... ... 2017 , ... People are starting to accept that hearing aids can be ... the stigma it had when great-grandpa wore his hearing aids years ago,” said Dr. ... North American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates ... leading ERP expert that specializes in long-term care, Brooke Grove now has the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. , with ... B. Braun Medical Inc. , a leader in infusion therapy and pain management. ... many as 90 percent of hospital patients receiving a peripheral IV catheter as part ...
(Date:4/27/2017)... ... April 27, 2017 , ... The ... the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a prestigious ... Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. Attorney ...
Breaking Medicine News(10 mins):
(Date:4/25/2017)... 2017 Endo International plc (NASDAQ: ENDP ) ... of its senior management team will host a conference call and ... The dial-in number to access the call is ... the passcode is 6086379. Please dial in 10 minutes prior to ... replay of the call will be available from May 9, 2017 ...
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
Breaking Medicine Technology: